Quoin Pharmaceuticals Quote - QNRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.614

Bid

0.58

Offer

0.614

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

3.101M

Previous Close

0.614

Open

Last Trade

0.614

Last Trade Time

20:10:11

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

5,049,720

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

Net Profit

-8.69M

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Neth... Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. Show more

Sector

Medicinal Chems,botanicl Pds

Industry

Cmp Programming,data Process

Website

www.cellect.co

Headquarters

Kfar Saba, Center, Isr

Founded

2007

Quoin Pharmaceuticals Ltd is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker QNRX. The last closing price for Quoin Pharmaceuticals was US$0.61. Over the last year, Quoin Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Quoin Pharmaceuticals currently has 5,049,720 shares in issue. The market capitalisation of Quoin Pharmaceuticals is US$3.10 million.

Form 8-K - Current report

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Continued Significant Improvement in Skin Appearance Observed in StudySubject’s Disease Classification Improved from “Severe” to “Mild” after 6 Weeks Dosing Treatment area expanded from 20% Body...

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s...

Form 8-K - Current report

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical Benefits from QRX003 Observed Across All Measured...

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

QNRX - Frequently Asked Questions (FAQ)

What is the current Quoin Pharmaceuticals share price?

The current share price of Quoin Pharmaceuticals is US$ 0.614

How many Quoin Pharmaceuticals shares are in issue?

Quoin Pharmaceuticals has 5,049,720 shares in issue

What is the market cap of Quoin Pharmaceuticals?

The market capitalisation of Quoin Pharmaceuticals is USD 3.1M

What is the 1 year trading range for Quoin Pharmaceuticals share price?

Quoin Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the reporting currency for Quoin Pharmaceuticals?

Quoin Pharmaceuticals reports financial results in USD

What is the latest annual profit for Quoin Pharmaceuticals?

The latest annual profit of Quoin Pharmaceuticals is USD -8.69M

What is the registered address of Quoin Pharmaceuticals?

The registered address for Quoin Pharmaceuticals is 23 HATA’AS STREET, KFAR SABA, CENTER, 44425

What is the Quoin Pharmaceuticals website address?

The website address for Quoin Pharmaceuticals is www.cellect.co

Which industry sector does Quoin Pharmaceuticals operate in?

Quoin Pharmaceuticals operates in the CMP PROGRAMMING,DATA PROCESS sector

Symbol	Price	Vol.
IPAImmunoPrecise Antibodies Ltd	US$ 0.7756 (57.32%)	7.93M
CDIOCardio Diagnostics Holdings Inc	US$ 0.8751 (43.93%)	6.89M
NEHCNew Era Helium Inc	US$ 3.875 (41.42%)	1.27M
ADAGAdagene Inc	US$ 2.50 (41.08%)	3
NFXLDirexion Daily NFLX Bull 2X Shares	US$ 45.04 (27.70%)	7.63k
ABLAbacus Life Inc	US$ 3.01 (-59.97%)	31
ARTVArtiva Biotherapeutics Inc	US$ 5.31 (-24.89%)	2
HTLMHomesToLife Ltd	US$ 5.97 (-23.66%)	10
TMCITreace Medical Concepts Inc	US$ 7.23 (-22.01%)	11
ELVNEnliven Therapeutics Inc	US$ 17.21 (-21.77%)	1
IPAImmunoPrecise Antibodies Ltd	US$ 0.7756 (57.32%)	7.93M
CDIOCardio Diagnostics Holdings Inc	US$ 0.8751 (43.93%)	6.89M
ASSTAsset Entities Inc	US$ 1.14 (26.67%)	5.73M
RIMEAlgorhythm Holdings Inc	US$ 0.0398 (15.03%)	4.81M
SHViShares Short Treasury Bond ETF	US$ 110.365 (0.01%)	3.55M

Symbol

Price

Vol.